“道家补益禁方”对小鼠非特异性免疫功能的影响
The Effect of “The Tonifying Secret Recipe of Taoists” on Non-Specific Immune Function in Mice
摘要: 目的:探讨“道家补益禁方对小鼠非特异性免疫功能的影响,为其开发利用奠定基础。方法采用MTT法、溶血分光光度法、改良Mayer法及抗体芯片法检测小鼠非特异性免疫功能及细胞因子含量。结果应用道家补益禁方小鼠的NK细胞杀伤力、CH50活性均增加;IL 2含量显著提高IL 8分泌减少。结论道家补益禁方能提高小鼠的非特异性免疫应答水平,调节细胞因子分泌,可以有效地增强机体非特异性免疫功能。 Objective: To explore the effect of “The tonifying secret recipe of Taoists” on non-specific immune function in mice, to establish the foundation for its development and utilization. Methods: To assay the immunity function and cytokine of mice with MTT, hemolysis spectrophotometric method, improved Mayer method and ELISA method. Results: “The tonifying secret recipe of Taoists” improved activity of NK and the total complement activity in serum, while increasing content of IL 2 and reduced that of IL 8. Conclusion: “The tonifying secret recipe of Taoists” could reinforce non-specific immune response, accommodate lymphocyte to secrete cytokine and enhance the body’s non-specific immune function effectively.
文章引用:宗庆芸, 胜利, 何江涛. “道家补益禁方”对小鼠非特异性免疫功能的影响[J]. 免疫学研究, 2013, 1(3): 11-13. http://dx.doi.org/10.12677/IS.2013.13003

参考文献

[1] 马继兴 (1991) 继敦煌残卷中发现《内经》古诊法后的再发现. 上海中医药杂志, 5, 38-40.
[2] 赵建雄 (1989) 敦煌遗书“残医书” 卷考析. 中国医药学报, 4, 53-55.
[3] 刘喜平 (2006) 敦煌古医药方研究. 第1版, 科学普及出版社, 北京, 367-368.
[4] Falchetti, R., Fuggetta, M.P., Lanzilli, G., et al. (2001) Effect of resveratrol on human immune cell function. Life Sciences, 70, 81-96.
[5] 李明琦, 白雪峰, 王锡山 (2012) 自然杀伤细胞的基础研究和进展. 国际免疫学杂志, 35, 90-94.
[6] 王会会, 陈国江, 黎 燕等 (2010) 补体C5a、C5a受体及其拮抗剂的研究进展. 国际药学研究杂志, 37, 181-186.
[7] 张晓明, 苗榕生, 唐岩等 (2000) 白细胞介素2和黄芪多糖对人NK细胞活性和增殖的影响. 北京中医药大学学报, 12, 27-29.
[8] 周显青, 牛翠娟, 孙儒泳 (2002) 黄芪和酸应激对中华鳖幼鳖血清补体C3和C4含量的影响. 动物学研究, 23, 177-180.
[9] Jin, B.Q. (2001) Cell and molecular immunology (Version 2). Science Publisher, Peking, 475-479.
[10] Paul, Compile, Wu, Y.Z., et al. Translate. (2003) Basi immunol- ogy. Science Publisher, Peking, 655-657.
[11] Reddy, K.P., Markowitz, J.E., Ruchelli, E.D., et al. (2007) Lam- ina propria and circulating interleukin 8 in newly and previously diagnosed pediatric inflammatory bowel disease patients. Diges- tive Diseases and Sciences, 52, 365-372.